Lemaitre Vascular Stock Today
| LMAT Stock | USD 64.23 1.46 2.33% |
Performance6 of 100
| Odds Of DistressLess than 3
|
LeMaitre Vascular is selling for under 64.23 as of the 24th of April 2024; that is 2.33 percent up since the beginning of the trading day. The stock's last reported lowest price was 62.77. LeMaitre Vascular has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for LeMaitre Vascular are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of April 2023 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 19th of October 2006 | Category Healthcare | Classification Health Care |
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. The company has 22.45 M outstanding shares of which 775.2 K shares are now shorted by private and institutional investors with about 4.96 trading days to cover. More on LeMaitre Vascular
Moving together with LeMaitre Stock
| 0.63 | FORA | Forian Inc Financial Report 10th of May 2024 | PairCorr |
| 0.69 | DHR | Danaher Buyout Trend | PairCorr |
| 0.67 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
Moving against LeMaitre Stock
| 0.73 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
| 0.69 | ICCM | Icecure Medical Financial Report 27th of May 2024 | PairCorr |
| 0.68 | SIBN | Si Bone Financial Report 6th of May 2024 | PairCorr |
| 0.61 | SRDX | SurModics Earnings Call This Week | PairCorr |
| 0.59 | SINT | SINTX Technologies | PairCorr |
| 0.55 | HCAT | Health Catalyst Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 7th of May 2024
LeMaitre Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. LeMaitre Vascular's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding LeMaitre Vascular or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman and CEO | George LeMaitre | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering LeMaitre Vascular report their recommendations after researching LeMaitre Vascular's financial statements, talking to executives and customers, or listening in on LeMaitre Vascular's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering LeMaitre Vascular. The LeMaitre consensus assessment is calculated by taking the average forecast from all of the analysts covering LeMaitre Vascular. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of LeMaitre Vascular's profitability, liquidity, and operating efficiency, LeMaitre Vascular is doing better financially then in previous quarter. It has a moderate probability of reporting better financial numbers in May. Financial strength of LeMaitre Vascular is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LeMaitre Vascular's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to LeMaitre Vascular's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LeMaitre Vascular's financial leverage. It provides some insight into what part of LeMaitre Vascular's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LeMaitre Vascular (LMAT) is traded on NASDAQ Exchange in USA. It is located in 63 Second Avenue, Burlington, MA, United States, 01803 and employs 614 people. LeMaitre Vascular is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LeMaitre Vascular's market, we take the total number of its shares issued and multiply it by LeMaitre Vascular's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. LeMaitre Vascular conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 22.45 M outstanding shares of which 775.2 K shares are now shorted by private and institutional investors with about 4.96 trading days to cover.
LeMaitre Vascular currently holds about 75.68 M in cash with 36.75 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45.
Check LeMaitre Vascular Probability Of Bankruptcy
Ownership AllocationLeMaitre Vascular maintains a total of 22.45 Million outstanding shares. The majority of LeMaitre Vascular outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LeMaitre Vascular to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in LeMaitre Vascular. Please pay attention to any change in the institutional holdings of LeMaitre Vascular as this could imply that something significant has changed or is about to change at the company. Also note that almost two hundred twenty-four thousand four hundred sixty invesors are currently shorting LeMaitre Vascular expressing very little confidence in its future performance.
Check LeMaitre Ownership Details
LeMaitre Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of LeMaitre Vascular jumping above the current price in 90 days from now is about 40.34%. The LeMaitre Vascular probability density function shows the probability of LeMaitre Vascular stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.0668. This indicates LeMaitre Vascular market returns are related to returns on the market. As the market goes up or down, LeMaitre Vascular is expected to follow. Additionally, leMaitre Vascular has an alpha of 0.0576, implying that it can generate a 0.0576 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of LeMaitre Vascular to move above the current price in 90 days from now is about 40.34 (This LeMaitre Vascular probability density function shows the probability of LeMaitre Stock to fall within a particular range of prices over 90 days) .
LeMaitre Stock Institutional Holders
Institutional Holdings refers to the ownership stake in LeMaitre Vascular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of LeMaitre Vascular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing LeMaitre Vascular's value.| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2023-12-31 | 309 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 294.6 K | |
| Ameriprise Financial Inc | 2023-12-31 | 285.4 K | |
| Kennedy Capital Management Inc | 2023-12-31 | 236.4 K | |
| Rice Hall James & Associates, Llc | 2023-12-31 | 232.2 K | |
| Awm Investment Company Inc | 2023-12-31 | 230 K | |
| Summit Creek Advisors Llc | 2023-12-31 | 228.5 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 216.2 K | |
| Envestnet Asset Management Inc | 2023-12-31 | 203.8 K | |
| Blackrock Inc | 2023-12-31 | 3.3 M | |
| Conestoga Capital Advisors, Llc | 2023-12-31 | 1.9 M |
LeMaitre Vascular Historical Income Statement
LeMaitre Vascular Income Statement is one of the three primary financial statements used for reporting LeMaitre's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of LeMaitre Vascular revenue and expense. LeMaitre Vascular Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, LeMaitre Vascular's Income Before Tax is comparatively stable compared to the past year. Net Income is likely to gain to about 31.6 M in 2024, whereas Total Other Income Expense Net is likely to drop slightly above 1.4 M in 2024. View More FundamentalsLeMaitre Stock Against Markets
Picking the right benchmark for LeMaitre Vascular stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in LeMaitre Vascular stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for LeMaitre Vascular is critical whether you are bullish or bearish towards LeMaitre Vascular at a given time. Please also check how LeMaitre Vascular's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in LeMaitre Vascular without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
LeMaitre Vascular Corporate Directors
LeMaitre Vascular corporate directors refer to members of a LeMaitre Vascular board of directors. The board of directors generally takes responsibility for the LeMaitre Vascular's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of LeMaitre Vascular's board members must vote for the resolution. The LeMaitre Vascular board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Cornelia LeMaitre | VP of HR and Director | Profile | |
| Giovannella Deiure | Director, Southern Europe | Profile | |
| Lawrence Jasinski | Independent Director | Profile | |
| James Russell | Director, Operations | Profile |
How to buy LeMaitre Stock?
Before investing in LeMaitre Vascular, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in LeMaitre Vascular. To buy LeMaitre Vascular stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of LeMaitre Vascular. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase LeMaitre Vascular stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located LeMaitre Vascular stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased LeMaitre Vascular stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as LeMaitre Vascular, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.
Already Invested in LeMaitre Vascular?
The danger of trading LeMaitre Vascular is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of LeMaitre Vascular is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than LeMaitre Vascular. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile LeMaitre Vascular is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether LeMaitre Vascular is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if LeMaitre Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Lemaitre Vascular Stock. Highlighted below are key reports to facilitate an investment decision about Lemaitre Vascular Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.Note that the LeMaitre Vascular information on this page should be used as a complementary analysis to other LeMaitre Vascular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for LeMaitre Stock analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is LeMaitre Vascular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeMaitre Vascular. If investors know LeMaitre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LeMaitre Vascular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.48 | Dividend Share 0.56 | Earnings Share 1.34 | Revenue Per Share 8.709 | Quarterly Revenue Growth 0.194 |
The market value of LeMaitre Vascular is measured differently than its book value, which is the value of LeMaitre that is recorded on the company's balance sheet. Investors also form their own opinion of LeMaitre Vascular's value that differs from its market value or its book value, called intrinsic value, which is LeMaitre Vascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LeMaitre Vascular's market value can be influenced by many factors that don't directly affect LeMaitre Vascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LeMaitre Vascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if LeMaitre Vascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LeMaitre Vascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.